Refractive errors, road traffic accidents and long-term spectacle compliance amongst commercial taxi drivers in a major North-East Indian city.


Journal

Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376

Informations de publication

Date de publication:
06 2022
Historique:
entrez: 1 6 2022
pubmed: 2 6 2022
medline: 7 6 2022
Statut: ppublish

Résumé

To assess the prevalence of refractive error (RE) and its association with road traffic accidents (RTAs) and the subsequent long-term spectacle compliance and adherence to suggested appropriate strategies In Shillong, India. prospective study was conducted between July and October 2019 among commercial taxi drivers (CTDs), with follow-up interviews conducted with a subset of respondents to assess long-term spectacle compliance after a year. Gross ophthalmologic examination was performed, including visual acuity and refraction. Descriptive statistics and Chi-square tests were conducted to assess the association between the type of REs, spectacle compliance, and selected sociodemographic and clinical variables. Multiple logistic regression was performed for analysis of the association between RTAs and sociodemographic, clinical, and work characteristics variables. A total of 382 (95.5%) CTDs completed interviews and gross eye examination. The prevalence of any RE in the worst eye was 28.8% (95% CI: 24.3-33.6). Presbyopia with or without distance vision was the commonest type of RE with 21.7% (95% CI: 17.7%-26.2). Among those who were prescribed spectacles, 70.5% needed near correction. Drivers with RE were nearly two times (OR: 2.6; 95% CI: 1.4-5.1) more likely to be involved in RTAs compared to those without any RE. Long-term spectacle compliance was at 40.9%. The predominant barrier reported for spectacle compliance was "can manage well without spectacles." This survey has demonstrated a significant relationship between poor vision and occurrence of RTAs. There is an urgent need for tailor-made targeted interventions to address the eye health needs of CTDs in India.

Identifiants

pubmed: 35647996
pii: IndianJOphthalmol_2022_70_6_2118_346165
doi: 10.4103/ijo.IJO_3106_21
pmc: PMC9359236
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2118-2124

Déclaration de conflit d'intérêts

None

Références

Indian J Occup Environ Med. 2007 May;11(2):71-5
pubmed: 21938219
J Optom. 2016 Jan-Mar;9(1):54-63
pubmed: 26364760
Springerplus. 2014 Jan 24;3:47
pubmed: 24505558
Afr Health Sci. 2011 Mar;11(1):97-102
pubmed: 21572864
J Public Health Afr. 2019 Jun 04;10(1):789
pubmed: 31244981
Ann Ital Chir. 2009 Jan-Feb;80(1):43-8; discussion 48
pubmed: 19537123
Ophthalmology. 1999 Jun;106(6):1066-72
pubmed: 10366072
PLoS One. 2015 Mar 17;10(3):e0118675
pubmed: 25781940
Cochrane Database Syst Rev. 2011 Mar 16;(3):CD006252
pubmed: 21412894
Accid Anal Prev. 2013 Jan;50:451-5
pubmed: 22683278
Invest Ophthalmol Vis Sci. 1999 Nov;40(12):2810-8
pubmed: 10549640
Lancet Glob Health. 2017 Sep;5(9):e888-e897
pubmed: 28779882
BMC Ophthalmol. 2021 Mar 23;21(1):148
pubmed: 33757436
Invest Ophthalmol Vis Sci. 2000 Aug;41(9):2486-94
pubmed: 10937558
Can J Ophthalmol. 2009 Jun;44(3):261-4
pubmed: 19491978
Invest Ophthalmol Vis Sci. 1997 Feb;38(2):334-40
pubmed: 9040465
Ethiop Med J. 2013 Apr;51(2):123-32
pubmed: 24079156
Afr J Med Med Sci. 2011 Dec;40(4):405-11
pubmed: 22783693
Arch Ophthalmol. 1989 Jul;107(7):991-7
pubmed: 2751471
Lancet Glob Health. 2021 Feb;9(2):e130-e143
pubmed: 33275950

Auteurs

S G Prem Kumar (SGP)

Mission for Vision, Mumbai, Maharashtra, India.

Aaron Basaiawmoit (A)

Bansara Eye Care Centre, Shillong, Meghalaya, India.

Dorcas W Marbaniang (DW)

Bansara Eye Care Centre, Shillong, Meghalaya, India.

Kyntiew Daplin Nongsiej (KD)

Bansara Eye Care Centre, Shillong, Meghalaya, India.

Toshimenla Pongen (T)

Bansara Eye Care Centre, Shillong, Meghalaya, India.

Jennifer Vaid Basaiawmoit (JV)

Bansara Eye Care Centre, Shillong, Meghalaya, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH